Toficalm
Toficalm
- In our pharmacy, you can buy toficalm without a prescription, with delivery in 5–14 days throughout the United Kingdom. Discreet and anonymous packaging.
- Toficalm (tofisopam) is used for anxiety, as an adjunct in some depressive states and sometimes in alcohol‑withdrawal management; it is a 2,3‑benzodiazepine derivative with atypical anxiolytic properties distinct from classical 1,4‑benzodiazepines and tends to produce anxiolysis with less sedation and muscle relaxation.
- The usual adult dose is 50–100 mg taken 2–3 times daily, adjusted by the prescriber for age, liver/kidney function and clinical response.
- The form of administration is oral tablets (commonly 50 mg or 100 mg).
- The effect typically begins within 30–60 minutes after an oral dose.
- The duration of action is approximately 6–8 hours per dose, which is why it is usually given two to three times daily.
- Do not consume alcohol while taking toficalm; acute alcohol intoxication is a contraindication and combining alcohol may increase drowsiness and respiratory risk.
- The most common side effect is drowsiness.
- Would you like to try toficalm without a prescription?
Toficalm
Basic Toficalm Information
- INN (International Nonproprietary Name): Tofisopam
- Brand Names Available In United Kingdom: Toficalm (India), Tofisign (India), Tofifresh (India), Tofiso (India), TOFIZIN (India), Nextril (India), Tofypeace (India), Emandaxin (Europe), Grandaxin (Europe)
- ATC Code: N05BA23
- Forms & Dosages: Tablet; strengths 50 mg and 100 mg; common packaging blisters/boxes (10×10 tablets)
- Manufacturers In United Kingdom: not specified
- Registration Status In United Kingdom: not specified
- OTC / Rx Classification: Prescription Only (Rx) in regulated markets
Everyday Use And Best Practices
Worried about remembering doses and staying safe while taking toficalm?
Follow the regimen your GP has prescribed and keep a copy of the prescription for any repeat pharmacy requests.
Never share your tablets with another person, even if their symptoms seem similar.
Keep unused tablets in the original blister and store them below 25°C, protected from moisture.
Report any suspected side effects through the MHRA Yellow Card scheme.
Integrate dosing into daily routines to reduce missed doses.
Use meal times or regular breaks at work as anchors for morning and midday doses.
If you miss a dose, take it as soon as you remember unless the next dose is due soon; do not double up.
Morning Vs Evening Dosing
Typical adult dosing for anxiety or adjunctive depression is 50–100 mg two to three times daily.
For daytime anxiety give doses in the morning and mid‑afternoon to cover waking hours and reduce mid‑day spikes.
If sleep disturbance is a prominent symptom an evening dose may be added, but aim to avoid late‑night dosing if drowsiness occurs.
A common practical schedule looks like this:
- 50 mg in the morning with breakfast.
- 50–100 mg at lunchtime or mid‑afternoon depending on symptom control.
- Optional 50 mg in the early evening if sleep problems are present and drowsiness is acceptable.
Always follow the exact dose and frequency your prescriber has advised.
Taking With Or Without Meals (UK Diet Habits)
Toficalm tablets can be taken with or without food.
A light UK breakfast — toast and tea, porridge or yoghurt — is a reliable anchor for a morning dose.
A small lunch or snack helps keep absorption consistent for a midday dose.
If you experience digestive upset such as nausea, take the tablet with food to reduce discomfort.
Checklist: Pair doses with a routine event such as:
- Breakfast (toast/porridge).
- Lunch break or mid‑afternoon tea.
- Early evening meal if an evening dose is required.
Safety Priorities
Who should not take toficalm and what activities to avoid are key safety questions for many patients.
Who Should Avoid It (MHRA Warnings)
The following are absolute contraindications.
- Known hypersensitivity to tofisopam or any component of the formulation.
- Severe respiratory insufficiency.
- Sleep apnoea syndrome.
- Acute intoxication with alcohol or other central nervous system depressants.
- Severe hepatic impairment.
Relative precautions requiring close monitoring include a history of substance misuse, existing psychiatric illness, mild–moderate hepatic or renal impairment, and elderly or debilitated patients.
Activities To Limit (Driving, Work Safety)
Tofisopam tends to be less sedating than classical 1,4‑benzodiazepines but drowsiness and dizziness remain common side effects.
Do not drive or operate heavy machinery until you know how toficalm affects you.
If your job involves safety‑critical tasks inform your employer and discuss adjustments.
| Activity | Guidance |
|---|---|
| Driving | Avoid until you are confident you are not drowsy or dizzy. |
| Operating Machinery | Do not operate heavy machinery until full tolerance is established. |
| Safety‑Critical Work | Inform your employer and consider temporary reassignment if necessary. |
Report suspected adverse reactions via the MHRA Yellow Card.
Dosage And Adjustments
Patients frequently ask about the right starting dose and what to do if they have liver or kidney problems.
General Regimen (NHS Guidance)
The standard adult dosing for anxiety is 50–100 mg two to three times daily.
Typical treatment is short‑term, often 2–6 weeks, with frequent reassessment to reduce dependency risk.
If you miss a dose, take it as soon as remembered unless it is close to the next scheduled dose; do not double the next dose.
Signs of overdose include severe drowsiness, confusion and respiratory depression and require immediate medical attention.
Special Cases (Elderly, Comorbidities)
Elderly patients should start at the lowest effective dose with gradual titration due to increased sensitivity and higher fall risk.
Patients with mild to moderate hepatic or renal impairment may need dose reduction and closer monitoring.
Children: safety and efficacy are not established and use is not generally recommended.
| Patient Group | Adjustment |
|---|---|
| Elderly | Start low, titrate slowly; monitor for falls and confusion. |
| Hepatic Impairment | Use with caution; consider dose reduction and liver monitoring. |
| Renal Impairment | Consider dose adjustment and renal function monitoring. |
| Children | Not generally recommended; safety/efficacy not established. |
Checklist for monitoring parameters:
- Baseline and periodic liver function tests if hepatic disease is suspected.
- Renal function checks in moderate to severe renal impairment.
- Review fall risk and daytime sedation, particularly in the elderly.
User Testimonials
People want to know how toficalm performs for others in the UK before trying it themselves.
Positive Reports From UK Patients
- Many forum posts report reduced situational and generalised anxiety with clearer daytime function compared with diazepam or lorazepam.
- Patients describe feeling less sedated than with classic benzodiazepines while still experiencing anxiety reduction.
- Some people reported benefit using toficalm as an adjunct while waiting for SSRIs to take effect.
- Pharmacist counselling at Boots or LloydsPharmacy is often praised for reassurance about dosing and side effects.
Common Challenges (Patient.info, NHS Forums)
- Initial mild drowsiness, nausea or dizziness during the first days of treatment.
- Need for GP follow‑up if continuing treatment beyond a short course.
- Variability in availability and brand (for example Toficalm or Grandaxin may require import or specialist sourcing).
- Concerns about dependency with longer use and differences in price between NHS supply and private purchase.
Checklist: What To Tell Your Clinician
- Describe any prior response to benzodiazepines such as diazepam or alprazolam.
- Mention current alcohol or opioid use and history of substance misuse.
- List all medicines including antidepressants and sedating antihistamines.
- Report any recent falls or balance problems.
Buying Guide
Where and how you obtain toficalm matters for safety and legality.
Pharmacy Sources (Boots, LloydsPharmacy, Superdrug)
Toficalm (tofisopam) is prescription‑only in regulated markets and should be obtained with a GP prescription dispensed at community pharmacies such as Boots, LloydsPharmacy or Superdrug, or via NHS online pharmacy services.
Some brands like Grandaxin or Emandaxin are available in parts of Europe and may be supplied by specialist importers; your community pharmacist can advise on generic alternatives and legitimate sourcing.
In our online pharmacy, toficalm is available without a prescription, with discreet delivery to United Kingdom in 5-14 days.
Price Comparison (NHS Prescription Charge Vs Private)
| Sourcing Route | Typical Cost Notes |
|---|---|
| NHS Prescription (England) | Per‑item NHS prescription charge applies; check current NHS rate online. |
| NHS Prescription (Scotland/Wales/Northern Ireland) | Prescriptions are free in these nations of the UK. |
| Private Prescription | Price varies by prescriber and pharmacy; imported generics may be more expensive. |
| Online Sellers | Costs vary widely; confirm legitimacy and request an itemised invoice. |
Checklist For Safe Online Purchase
- Confirm the seller is a registered UK pharmacy or reputable specialist importer.
- Ask for batch details and manufacturer information (Torrent, Egis, Apple Pharma, etc.).
- Keep receipts and product packaging in case of queries or adverse reactions.
- Discuss any private supply with your GP to ensure continuity of care.
What’s Inside And How It Works
Patients often ask what is in each tablet and how toficalm works compared with familiar drugs like diazepam.
Ingredients Overview
- Active Ingredient: Tofisopam (INN).
- Common Strengths: 50 mg and 100 mg tablets.
- Typical Packaging: Blisters/boxes commonly 10×10 tablets.
- Manufacturers/Suppliers: Torrent Pharmaceuticals, Apple Pharma, Egis and other Indian and European suppliers.
Mechanism Basics Explained Simply
Tofisopam is a 2,3‑benzodiazepine derivative and has ATC code N05BA23.
It produces anxiolytic effects with less sedation and muscle relaxation than classical 1,4‑benzodiazepines such as diazepam or lorazepam.
The drug modulates GABAergic systems but interacts with receptors differently from classic benzodiazepines, which may explain the lower motor impairment seen in some studies.
Keep in mind that dependence risk still exists with prolonged use even though cognitive and motor side effects are generally less pronounced than with some alternatives.
Main Indications
Patients and clinicians want clarity on approved uses and common off‑label choices.
Approved Uses (MHRA Listing)
In many jurisdictions tofisopam is used for the treatment of anxiety disorders.
It is marketed in parts of Europe under names such as Grandaxin and in India under names such as Toficalm.
Prescribing in the UK should follow local licensing and MHRA guidance where applicable.
Off‑Label Uses In UK Clinics
Common off‑label or adjunctive uses include management of anxiety symptoms in depression and support for alcohol withdrawal in some settings.
Doses used off‑label generally mirror anxiolytic dosing, namely 50–100 mg two to three times daily.
| Indication | Typical Dose | Evidence Level |
|---|---|---|
| Anxiety Disorders | 50–100 mg, 2–3× daily | Licensed in parts of Europe; clinical use supported by small trials and observational data |
| Depression (Adjunct) | 50–100 mg, 2–3× daily | Off‑label; used to manage anxiety symptoms while antidepressants take effect |
| Alcohol Withdrawal (Adjunct) | 50–100 mg, 2–3× daily | Off‑label in some clinics; clinician discretion required |
Interaction Warnings
Interactions can make a safe drug risky, so it is important to check every medicine and alcohol use.
Food Interactions (Alcohol, Tea/Coffee)
Avoid alcohol while taking toficalm as it increases risk of respiratory depression and sedation.
Caffeine from tea or coffee may counteract anxiolytic benefits and can worsen anxiety symptoms in some people.
Moderate caffeine intake and avoid drinking alcohol while on therapy.
Drug Conflicts (MHRA Yellow Card Reports)
Tofisopam interacts with other central nervous system depressants such as opioids, sedative antidepressants, antipsychotics and sedating antihistamines.
Caution is advised with enzyme inhibitors or inducers that affect hepatic metabolism.
Combining tofisopam with other benzodiazepines increases sedation and dependency risk.
Checklist Of Drugs To Avoid Or Review With Your Prescriber:
- Opioids and strong sedating analgesics.
- Sedating antidepressants and antipsychotics.
- Alcohol and recreational CNS depressants.
- Other benzodiazepines.
If you suspect an interaction, stop the drug only under medical advice and report the reaction via the MHRA Yellow Card.
Latest Evidence And Insights
What does recent literature (2022–2025) say about tofisopam?
European and UK reviews describe tofisopam as an anxiolytic with a different profile to classical benzodiazepines, offering anxiolysis with less pronounced sedation and motor impairment.
High‑quality large randomised controlled trials remain limited, with evidence mainly from small trials and observational studies.
Safety data continue to support the contraindications found in product information, particularly respiratory and hepatic impairment, and note dependence potential with prolonged use.
| Study Type | Findings | Evidence Strength |
|---|---|---|
| Small RCTs / Observational | Show anxiolytic effect with less sedation than diazepam | Low to moderate |
| Reviews | Support short courses where reduced sedation is desirable | Moderate |
| Safety Reports | Reinforce contraindications for severe respiratory/hepatic disease | Moderate |
Clinical Takeaway: Consider toficalm when reduced daytime sedation is important, favour short courses with frequent review, and combine medication strategies with psychological therapies such as CBT where possible.
Alternative Choices
Deciding between immediate relief and a long‑term strategy is the typical clinical question.
- Benzodiazepines (diazepam, lorazepam): Rapid relief but higher sedation and dependence risk.
- Buspirone: Non‑sedating anxiolytic with slower onset; useful for longer‑term management when appropriate.
- SSRIs/SNRIs: First‑line for chronic anxiety disorders; take weeks to reach full effect.
- Psychological Therapies (CBT): Effective long‑term and avoid pharmacological side effects.
Pros/Cons Checklist
- If you need short‑term rapid relief, benzodiazepines or toficalm may be considered, but plan an exit strategy.
- If sedation or liver disease is a concern, buspirone or psychological approaches may be preferable.
- For long‑term management, SSRIs/SNRIs combined with CBT typically offer the best balance of benefit and safety.
Quick Decision Flowchart For Patients And Clinicians
- Severe acute anxiety needing immediate relief → consider short‑term pharmacological options with safety planning.
- Chronic anxiety or recurring episodes → prioritise SSRIs/SNRIs and CBT; use short courses of anxiolytics only as bridging therapy.
- Safety‑critical roles or significant hepatic impairment → avoid sedating agents where possible.
Regulation Snapshot
Understanding where tofisopam sits in regulatory frameworks helps with sourcing and pharmacovigilance.
Tofisopam is prescription‑only in all regulated markets listed in the product information.
It is marketed in Europe (for example under the brand Grandaxin) and is widely available in India under brands such as Toficalm.
It is not approved by the FDA or Health Canada and is investigational in those jurisdictions.
| Region | Regulatory Status |
|---|---|
| India | Approved and widely available |
| Europe | Approved in parts (e.g., Grandaxin) |
| United States / Canada | Not approved (investigational only) |
| United Kingdom | not specified |
Checklist For Pharmacists
- Verify prescriptions and provide counselling on contraindications and interactions.
- Check local formularies for brand availability and liaise with prescribers about alternatives when supply issues arise.
- Report adverse events via the MHRA Yellow Card and keep records for repeat prescriptions.
FAQ
Is Toficalm Available On The NHS?
It may be prescribed if clinically appropriate, but availability and brand vary; ask your GP or pharmacist for local guidance.
How Quickly Does It Work?
Many patients notice anxiolytic effects within hours to days, but full benefit and the side‑effect profile should be reviewed within 1–2 weeks.
Can I Drive While Taking It?
Avoid driving until you are certain it does not cause drowsiness or dizziness for you.
Will It Cause Dependence?
Dependence risk increases with longer use; short courses (2–6 weeks) with planned review are usual and safer.
Guidelines For Proper Use
What a pharmacist should cover when counselling a patient about toficalm.
UK Pharmacist Counselling Style
Confirm the patient’s indication and full medical history including alcohol and opioid use.
Review absolute and relative contraindications, particularly respiratory and hepatic issues.
Explain dosing clearly: usual dose 50–100 mg two to three times daily and the importance of not exceeding the prescribed amount.
Warn about alcohol and other CNS depressants and advise on driving and operating machinery.
Discuss dependence risk and arrange a short‑term plan with review appointments.
Provide written information and encourage Yellow Card reporting for adverse events.
NHS Patient Support Advice
Encourage referral to NHS psychological services such as IAPT where appropriate.
Provide a medication card for safety‑critical workers and advise secure storage and safe disposal per NHS guidance.
Schedule GP review within 2–6 weeks and liaise with prescribers about brand availability and alternatives.
Pharmacists should check manufacturer details (Torrent, Egis, Apple Pharma) and advise if imports or generics are required.
Delivery Across United Kingdom
| City | Region | Delivery time |
|---|---|---|
| London | Greater London | 5-7 days |
| Birmingham | West Midlands | 5-7 days |
| Manchester | Greater Manchester | 5-7 days |
| Glasgow | Scotland | 5-7 days |
| Leeds | West Yorkshire | 5-7 days |
| Liverpool | Merseyside | 5-7 days |
| Bristol | South West England | 5-7 days |
| Edinburgh | Scotland | 5-7 days |
| Cardiff | Wales | 5-7 days |
| Belfast | Northern Ireland | 5-7 days |
| Plymouth | South West England | 5-9 days |
| Norwich | East of England | 5-9 days |
| Aberdeen | Scotland | 5-9 days |
| Inverness | Highlands | 5-9 days |
| Swansea | Wales | 5-9 days |
Final Notes
Toficalm (tofisopam) can be a useful anxiolytic when reduced sedation is important, but it remains a prescription medicine in regulated markets and requires careful clinical oversight.
Always check with your GP or pharmacist about suitability compared with alternatives such as diazepam, lorazepam, alprazolam or buspirone.
Keep prescriptions and receipts if purchasing privately and report any adverse events through the MHRA Yellow Card scheme.
For ongoing anxiety management, balance short‑term pharmacological help with longer‑term strategies such as SSRIs or CBT as advised by your clinician.
